Aspirin-Exacerbated Respiratory Disease: How to Diagnose and Treat AERD with Desensitization

What Is Aspirin-Exacerbated Respiratory Disease?

Aspirin-Exacerbated Respiratory Disease, or AERD, isn’t just a bad reaction to painkillers. It’s a chronic condition that hits adults between 20 and 50, mostly women, and it ties together three serious problems: asthma, chronic nasal polyps, and severe breathing reactions when taking common pain relievers like aspirin or ibuprofen. This trio is also called Samter’s Triad, named after the doctors who first mapped it out in the 1960s.

Unlike typical allergies, AERD doesn’t involve IgE antibodies or hay fever-style triggers like pollen. Instead, it’s rooted in how your body handles inflammation. When you take aspirin or other NSAIDs, your body overproduces leukotrienes - powerful inflammatory chemicals that swell your airways, clog your sinuses, and trigger asthma attacks. That’s why even if you avoid these drugs, your symptoms keep getting worse. The disease doesn’t wait for triggers; it keeps burning on its own.

How Do You Know If You Have AERD?

There’s no single blood test or scan that confirms AERD. Diagnosis comes down to your story - your symptoms, your history, and what happens when you’re exposed to NSAIDs.

If you’ve had asthma since adulthood, along with recurring nasal polyps that keep coming back after surgery, and you’ve ever had a bad reaction to aspirin, ibuprofen, or naproxen - you’re likely dealing with AERD. These reactions usually hit fast: within 30 to 120 minutes after swallowing the pill. You might get a stuffy nose, wheezing, chest tightness, or even full-blown asthma requiring emergency care.

When the history isn’t clear, doctors use a supervised aspirin challenge to confirm it. This isn’t something done at a regular clinic. It’s a controlled test in a hospital or allergy center with resuscitation equipment on standby. You start with a tiny dose - 20 to 30 milligrams - and it’s doubled every 90 to 120 minutes until you hit 325 mg or react. Most people complete it in 5 to 6 hours. If your breathing drops, your nose swells, or your peak flow falls by 20%, it’s confirmed.

Supporting clues include high eosinophils in your blood (over 500 cells/μL) and elevated leukotriene E4 in your urine. These aren’t diagnostic on their own, but they add weight when combined with your symptoms.

What Happens If You Just Avoid Aspirin and NSAIDs?

A lot of patients think avoiding NSAIDs will fix everything. It doesn’t. AERD keeps progressing even if you never touch another pill.

Nasal polyps grow back. Asthma gets harder to control. Your sense of smell fades - sometimes completely. One study found 78% of patients felt their daily life was severely limited by constant nasal congestion. About 45% needed at least one sinus surgery within two years of diagnosis.

Avoiding NSAIDs is still important - not because it cures AERD, but because it prevents dangerous flare-ups. But if you only avoid the drugs, you’re managing symptoms, not the disease. That’s why most patients need more than just avoidance.

Medical Treatments: What Actually Works?

There are three main layers of treatment: nasal rinses, inhalers, and targeted drugs.

High-volume steroid sinus rinses are the first-line defense. Using a squeeze bottle with 50 to 100 mg of budesonide, twice a day, can shrink polyps by 30 to 40% in just eight weeks. This isn’t a spray - it’s a full rinse that floods your sinuses. Most patients report better breathing and less post-nasal drip.

Intranasal sprays like fluticasone help too, but they’re not as powerful as rinses. They’re good for maintenance, especially if you can’t do rinses daily.

For asthma, standard treatment is a combination inhaler: fluticasone and salmeterol, two puffs twice a day. This improves lung function by 15 to 20% in most patients. But if your asthma is still flaring, you’re probably still inflamed deep in your airways.

That’s where leukotriene blockers come in. Zileuton (taken four times a day) cuts leukotriene production by 75% in two weeks. About 28% of users call it “extremely effective.” Montelukast (one pill a day) helps some, but only 15% report big improvements. It’s cheaper, but less powerful.

For severe cases, biologics are changing the game. Dupilumab, given as a shot every two weeks, reduces polyp size by 55% and improves quality of life scores by 40% in 16 weeks. Mepolizumab, given monthly, cuts eosinophil counts by 85% and reduces the need for repeat surgeries by 57%. These drugs don’t cure AERD, but they can stop the spiral - if you can afford them. Many patients struggle with cost, especially those under $50,000 a year in income.

Aspirin Desensitization: The Game-Changer

If you’ve had sinus surgery and your polyps keep coming back, you need to hear this: aspirin desensitization is the most effective long-term treatment for AERD.

The process starts like the diagnostic challenge - but it’s done with one goal: to make your body tolerate aspirin. You take increasing doses over two days, just like in the test, until you reach 325 mg without a reaction. Over 98% of patients make it through.

Then comes the hard part: you take 650 mg of aspirin twice a day - for life. No skipping. No breaks. Missing just two or three doses means you lose your tolerance and have to go through the whole process again.

But the payoff is huge. People who stick with it see:

• Polyp recurrence drop from 85% to 35% after two years
• Need for oral steroid bursts fall from 4.2 to 1.1 per year
• Improved sense of smell - 82% report major gains, with smell test scores jumping from 12.4 to 23.7 out of 40
• Less asthma flares, fewer ER visits, and better sleep

Studies show it’s cost-effective too. Each desensitization costs about $12,500 more than standard care - but it saves $18,500 per avoided sinus surgery. Over a lifetime, that’s tens of thousands saved.

Who Shouldn’t Try Desensitization?

It’s not for everyone. If you have severe heart disease, active peptic ulcers, or a history of stomach bleeding, aspirin can be dangerous. If you can’t commit to taking two pills every day, every single day - don’t start. You’ll end up worse off.

About 15% of potential candidates are ruled out because of these risks. Also, if you’ve had multiple failed surgeries or are already on high-dose biologics, your doctor might recommend skipping desensitization and focusing on meds instead.

Why Surgery Alone Isn’t Enough

Functional endoscopic sinus surgery (FESS) is common for AERD patients. It clears the blockage, opens the sinuses, and gives you immediate relief.

But here’s the truth: without aspirin desensitization, 60 to 70% of patients get polyps back within 18 months. Surgery fixes the damage - but it doesn’t stop the inflammation that causes it.

When you combine FESS with daily aspirin therapy, recurrence drops to 25 to 30% at two years. That’s a 65% reduction in polyp regrowth compared to surgery alone. Experts call this combo the gold standard. If you’re scheduled for surgery, ask your doctor if desensitization is right for you - before the operation.

Real Patient Experiences

Online communities like r/SamtersTriad and AERD Warriors are full of stories. One man said he hadn’t smelled coffee in 12 years. After desensitization, he cried the first time he smelled it again. Another woman said she stopped using her rescue inhaler for the first time in five years.

But it’s not all easy. About a third of patients say the desensitization process itself is brutal - nasal congestion, wheezing, and fatigue for hours. Some get stomach pain from daily aspirin and need to switch to enteric-coated versions or add a proton pump inhibitor.

And hidden NSAIDs? Big problem. Cold medicines, menstrual pain relievers, topical gels - all can trigger reactions. Patients learn to read labels like detectives.

Where Can You Get Help?

There are only about 35 dedicated AERD centers in the U.S., mostly at big academic hospitals. Most community allergists aren’t trained to do aspirin challenges or manage long-term desensitization. Only 18% of allergists feel confident handling AERD cases.

That’s why telemedicine has become a lifeline. Many patients start locally, then consult remotely with a specialist center for guidance on dosing, biologics, or desensitization planning. Penn Medicine and Brigham and Women’s Hospital have published open protocols and patient toolkits in eight languages - making it easier for doctors everywhere to follow best practices.

What’s Next for AERD Treatment?

The future is looking brighter. New drugs like tipelukast (MN-001), which blocks two inflammation pathways at once, are showing promise in early trials. Dupilumab combined with aspirin therapy is already proving better than either alone.

Regulators are stepping in too. The FDA’s 2023 draft guidelines are standardizing safety rules for aspirin challenges across the country. That means more centers will be able to offer the treatment safely.

But access is still unequal. Only 22% of rural AERD patients can reach a specialist within 100 miles. Insurance coverage for biologics and desensitization remains patchy. Until that changes, many will keep suffering - not because the treatments don’t work, but because they’re out of reach.

Bottom Line: You Can Take Back Control

AERD is not a death sentence. It’s not even a life sentence of constant misery. With the right diagnosis, the right combo of treatments - especially aspirin desensitization after surgery - you can regain your breathing, your smell, and your life.

It takes work. It takes commitment. But for the 14% of asthmatics with nasal polyps who have AERD, this is the most powerful intervention they’ll ever get.

Don’t accept worsening symptoms. Don’t assume your asthma is just getting worse. Ask your doctor: Could this be AERD? And if so - is desensitization right for me?